Coverage on Thoratec (NASDAQ: THOR), Allscripts Healthcare Solutions (NASDAQ: MDRX), Insulet Corp. (NASDAQ: PODD), SandRidge Mississippian Trust I (NYSE: SDT) and Golar LNG Partners (NASDAQ: GMLP) initiated by analysts.
Oppenheimer initiated coverage on Thoratec (NASDAQ: THOR). They placed an “outperform” rating and a price target of $40.00 on the company.
Robert W. Baird initiated coverage on Allscripts Healthcare Solutions (MDRX). They placed an “outperform” rating and a price target of $27.00 on the company.
Oppenheimer initiated coverage on Insulet Corp. (PODD). They placed an “outperform” rating and a price target of $25.00 on the company.
Robert W. Baird initiated coverage on SandRidge Mississippian Trust I (SDT). They placed a “neutral” rating and a price target of $25.00 on the company.
Wells Fargo & Co. (NYSE:WFC) initiated coverage on Golar LNG Partners (GMLP). They placed a “market perform” rating on the company.
Showing posts with label Insulet. Show all posts
Showing posts with label Insulet. Show all posts
Wednesday, May 18, 2011
Wednesday, May 11, 2011
Price Targets on (LMNX) (LOPE) (ONTY) (PAA) (PODD) Updated
Price targets on Luminex (NASDAQ: LMNX), Grand Canyon Education Incorporated (NASDAQ: LOPE), Oncothyreon Inc . (NASDAQ: ONTY), Plains All American (NYSE: PAA) and Insulet Corp. (NASDAQ: PODD) updated by analysts.
Jefferies (NYSE:JEF cut their price target on Luminex (LMNX) from $17.00 to $16.00. They have a “hold” rating on the company.
Bank of America (NYSE:BAC) cut their price target on Grand Canyon Education Incorporated (LOPE) from $18.00 to $17.00. They have a “neutral” rating on the company.
Wedbush raised their price target on Oncothyreon Inc . (ONTY) from $6.00 to $7.00.
Citigroup (NYSE:C) raised their price target on Plains All Amer (PAA) from $70.00 to $71.00. They have a “buy” rating on the company.
Jefferies (NYSE:JEF) raised their price target on Insulet Corp. (PODD) from $20.00 to $24.00. They have a “buy” rating on the company.
Jefferies (NYSE:JEF cut their price target on Luminex (LMNX) from $17.00 to $16.00. They have a “hold” rating on the company.
Bank of America (NYSE:BAC) cut their price target on Grand Canyon Education Incorporated (LOPE) from $18.00 to $17.00. They have a “neutral” rating on the company.
Wedbush raised their price target on Oncothyreon Inc . (ONTY) from $6.00 to $7.00.
Citigroup (NYSE:C) raised their price target on Plains All Amer (PAA) from $70.00 to $71.00. They have a “buy” rating on the company.
Jefferies (NYSE:JEF) raised their price target on Insulet Corp. (PODD) from $20.00 to $24.00. They have a “buy” rating on the company.
Tuesday, January 4, 2011
JPMorgan (NYSE:JPM) MedTech Favorites Include St. Jude (NYSE:STJ), Covidien (NYSE:COV), Insulet (Nasdaq:PODD), BioMimetic Therapeutics (Nasdaq:BMTI)
JPMorgan (NYSE:JPM) gave their 2011 outlook on numerous companies within the MedTech sector today, with their favorites being St. Jude (NYSE:STJ), Covidien (NYSE:COV), Insulet (Nasdaq:PODD) and BioMimetic Therapeutics (Nasdaq:BMTI)
Those companies with the sector JPMorgan expects to outperform include Becton, Dickinson and Company (NYSE:BDX), Stryker (NYSE:SYK), Varian Medical (NYSE:VAR), Edwards Lifesciences (NYSE:EW), Nxstage Medical (Nasdaq:NXTM), Hologic (Nasdaq:HOLX), Heartware (Nasdaq:HTWR), Volcano (Nasdaq:VOLC) and SonoSite (Nasdaq:SONO).
MedTech companies viewed with downside by JPMorgan are Intuitive Surgical (Nasdaq:ISRG), Boston Scientific (NYSE:BSX), Medtronic (NYSE:MDT), Wright Medical Group (Nasdaq:WMGI), CareFusion (NYSE:CFN), Thoratec (Nasdaq:THOR) NuVasive (Nasdaq:NUVA), Mako Surgical (Nasdaq:MAKO) and American Medical Systems (Nasdaq:AMMD).
St. Jude closed Tuesday at $42.28, losing $0.47, or 1.10 percent. Covidien closed at $47.45, gaining $1.79, or 3.92 percent. Insulet ended the day at $16.07, up $0.57, or 3.68 percent. BioMimetic Therapeutics closed at $13.46, up $0.76, or 5.98 percent.
Those companies with the sector JPMorgan expects to outperform include Becton, Dickinson and Company (NYSE:BDX), Stryker (NYSE:SYK), Varian Medical (NYSE:VAR), Edwards Lifesciences (NYSE:EW), Nxstage Medical (Nasdaq:NXTM), Hologic (Nasdaq:HOLX), Heartware (Nasdaq:HTWR), Volcano (Nasdaq:VOLC) and SonoSite (Nasdaq:SONO).
MedTech companies viewed with downside by JPMorgan are Intuitive Surgical (Nasdaq:ISRG), Boston Scientific (NYSE:BSX), Medtronic (NYSE:MDT), Wright Medical Group (Nasdaq:WMGI), CareFusion (NYSE:CFN), Thoratec (Nasdaq:THOR) NuVasive (Nasdaq:NUVA), Mako Surgical (Nasdaq:MAKO) and American Medical Systems (Nasdaq:AMMD).
St. Jude closed Tuesday at $42.28, losing $0.47, or 1.10 percent. Covidien closed at $47.45, gaining $1.79, or 3.92 percent. Insulet ended the day at $16.07, up $0.57, or 3.68 percent. BioMimetic Therapeutics closed at $13.46, up $0.76, or 5.98 percent.
Subscribe to:
Posts (Atom)